ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch
By filer · By stock

$CAPR:NASDAQ · Capricor Therapeutics Inc - US

Sector: health

Conviction from: NASDAQ

52-week range: 2.9640.37

Cell therapy biotech (Duchenne muscular dystrophy)

2 tracked filer(s) hold this · 0 opened, 1 added, 1 trimmed in 30-JUN-2026

Aggregate 13FScore 70 — mean of 2 scored holder(s) · buyers (new/add) avg 63. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor63Added +120%15,816$380,8490.0%
Steve Cohen / Point7276Trimmed -88%94,723$2,280,9300.0%

Beyond 13F — activists, insiders, politicians & research

Serenity (@aleabitoreddit) full tracker →

Watching · 1 mention(s), 0 personal-position post(s) · first 2026-09-06 · last 2026-09-06

“I asked OpenAI Astra Ultra + Anthropic Fable 5.1 Max to make me a 5x-10x return type portfolio in 1 year. Burnt a lot of credits, and the results are in: OpenAI: - $KYTX (autoimmune CAR-T results) - $PRQR (human RNA-editing datasets) - $VSTM (KRAS cancer-drug) - $CNTB (asthma and COPD) - $RANI (oral biologics) - $IVA (MASH) - $SILC (networking + inference hardware) - $AMPX (batteries) - $EOSE …” post →

All 1 tweet(s) mentioning this ticker
DateTweet
2026-09-06T14:23:02I asked OpenAI Astra Ultra + Anthropic Fable 5.1 Max to make me a 5x-10x return type portfolio in 1 year. Burnt a lot of credits, and the results are in: OpenAI: - $KYTX (autoimmune CAR-T results) - $PRQR (human RNA-editing datasets) - $VSTM (KRAS cancer-drug) - $CNTB (asthma and COPD) - $RANI (… → · 4993 likes · 1,338,791 views

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.